|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sha D, Lee AM, Shi Q, Alberts SR, Sargent
DJ, Sinicrope FA and Diasio RB: Association study of the let-7
miRNA-complementary site variant in the 3′ untranslated region of
the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical
Trial). Clin Cancer Res. 20:3319–3327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hiramoto H, Muramatsu T, Ichikawa D,
Tanimoto K, Yasukawa S, Otsuji E and Inazawa J: miR-509-5p and
miR-1243 increase the sensitivity to gemcitabine by inhibiting
epithelial-mesenchymal transition in pancreatic cancer. Sci Rep.
7:40022017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang XH and Wu X: miRNA expression profile
of vulvar squamous cell carcinoma and identification of the
oncogenic role of miR-182-5p. Oncol Rep. 35:398–408. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acid Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J,
Lu W, Wan X, Ma D and Xie X: Progressive miRNA expression profiles
in cervical carcinogenesis and identification of HPV-related target
genes for miR-29. J Pathol. 224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu S, Shi N, Wheler J, Naing A, Janku F,
Piha-Paul S, Gong J, Hong D, Tsimberidou A, Zinner R, et al:
Characteristics and outcomes for patients with advanced vaginal or
vulvar cancer referred to a phase I clinical trials program: The MD
Anderson Cancer Center experience. Gynecol Oncol Res Pract.
2:102015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Economopoulou P, Agelaki S, Perisanidis C,
Giotakis EI and Psyrri A: The promise of immunotherapy in head and
neck squamous cell carcinoma. Ann Oncol. 27:1675–1685. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tewari KS, Sill MW, Long HJ III, Penson
RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao
MM, et al: Improved survival with bevacizumab in advanced cervical
cancer. N Engl J Med. 370:734–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Melo Maia B, Lavorato-Rocha AM,
Rodrigues LS, Coutinho-Camillo CM, Baiocchi G, Stiepcich MM, Puga
R, de A Lima L, Soares FA and Rocha RM: microRNA portraits in human
vulvar carcinoma. Cancer Prev Res (Phila). 6:1231–1241. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Melo Maia B, Ling H, Monroig P, Ciccone
M, Soares FA, Calin GA and Rocha RM: Design of a miRNA sponge for
the miR-17 miRNA family as a therapeutic strategy against vulvar
carcinoma. Mol Cell Probes. 29:420–426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Melo Maia B, Rodrigues IS, Akagi EM,
Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA and
Rocha RM: MiR-223-5p works as an oncomiR in vulvar carcinoma by
TP63 suppression. Oncotarget. 7:49217–49231. 2016.PubMed/NCBI
|
|
14
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N,
Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression
levels can predict lymph node metastasis in patients with
early-stage cervical squamous cell carcinoma. Int J Mol Med.
32:557–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stark MS, Tyagi S, Nancarrow DJ, Boyle GM,
Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA and Hayward
NK: Characterization of the melanoma miRNAome by deep sequencing.
PLoS One. 5:e96852010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Wang HK, Li Y, Hafner M, Banerjee
NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al: microRNAs
are biomarkers of oncogenic human papillomavirus infections. Proc
Natl Acad Sci USA. 111:pp. 4262–4267. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park S, Eom K, Kim J, Bang H, Wang HY, Ahn
S, Kim G, Jang H, Kim S, Lee D, et al: MiR-9, miR-21 and miR-155 as
potential biomarkers for HPV positive and negative cervical cancer.
BMC Cancer. 17:6582017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wan Y, Vagenas D, Salazar C, Kenny L,
Perry C, Calvopiña D and Punyadeera C: Salivary miRNA panel to
detect HPV-positive and HPV-negative head and neck cancer patients.
Oncotarget. 8:99990–100001. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W,
Huang JA and Liu Z: Repression of Smad4 by miR-205 moderates
TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
Int J Oncol. 49:700–708. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ormanns S, Haas M, Remold A, Kruger S,
Kruger S, Holdenrieder S, Kirchner T, Heinemann V and Boeck S: The
impact of SMAD4 loss on outcome in patients with advanced
pancreatic cancer treated with systemic chemotherapy. Int J Mol
Sci. 18:E10942017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Yang J, Di J, Cui M, Xing J, Wu F,
Wu W, Yang H, Zhang C, Yao Z, et al: Downregulated USP3 mRNA
functions as a competitive endogenous RNA of SMAD4 by sponging
miR-224 and promotes metastasis in colorectal cancer. Sci Rep.
7:42812017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CC, Yang WH, Li CH, Cheng YW, Tsai CH
and Kang JJ: Ligand independent aryl hydrocarbon receptor inhibits
lung cancer cell invasion by degradation of Smad4. Cancer Lett.
376:211–217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park JW, Jang SH, Park DM, Lim NJ, Deng C,
Kim DY, Green JE and Kim HK: Cooperativity of E-cadherin and Smad4
loss to promote diffuse-type gastric adenocarcinoma and metastasis.
Mol Cancer Res. 12:1088–1099. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Phuah NH, Azmi MN, Awang K and Nagoor NH:
Down-regulation of microRNA-210 confers sensitivity towards
1′S-1′-acetoxychavicol acetate (ACA) in cervical cancer cells by
targeting SMAD4. Mol Cells. 40:291–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng H, Fertig EJ, Ozawa H, Hatakeyama H,
Howard JD, Perez J, Considine M, Thakar M, Ranaweera R, Krigsfeld G
and Chung CH: Decreased SMAD4 expression is associated with
induction of epithelial-to-mesenchymal transition and cetuximab
resistance in head and neck squamous cell carcinoma. Cancer Biol
Ther. 16:1252–1258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu N, Yu C, Shi Y, Jiang J and Liu Y:
SMAD4 expression in breast ductal carcinoma correlates with
prognosis. Oncol Lett. 10:1709–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hernanda PY, Chen K, Das AM, Sideras K,
Wang W, Li J, Cao W, Bots SJ, Kodach LL, de Man RA, et al: SMAD4
exerts a tumor-promoting role in hepatocellular carcinoma.
Oncogene. 34:5055–5068. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ling H, Pickard K, Ivan C, Isella C, Ikuo
M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, et al: The
clinical and biological significance of MIR-224 expression in
colorectal cancer metastasis. Gut. 65:977–989. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng D, Zhao S, Tang H, Zhang D, Sun H,
Yu F, Jiang W, Yue B, Wang J, Zhang M, et al: MicroRNA-20a-5p
promotes colorectal cancer invasion and metastasis by
downregulating Smad4. Oncotarget. 7:45199–45213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haeger SM, Thompson JJ, Kalra S, Cleaver
TG, Merrick D, Wang XJ and Malkoski SP: Smad4 loss promotes lung
cancer formation but increases sensitivity to DNA topoisomerase
inhibitors. Oncogene. 35:577–586. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Nie J, Chen L, Dong G, Du X, Wu X,
Tang Y and Han W: The oncogenic role of microRNA-130a/301a/454 in
human colorectal cancer via targeting Smad4 expression. PLoS One.
8:e555322013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osugi J, Muto S, Matsumura Y, Higuchi M,
Suzuki H and Gotoh M: Prognostic impact of the high-sensitivity
modified Glasgow prognostic score in patients with resectable
non-small cell lung cancer. J Cancer Res Ther. 12:945–951. 2016.
View Article : Google Scholar : PubMed/NCBI
|
